Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25


Phylogenetic, syntenic, and tissue expression analysis of slc22 genes in zebrafish (Danio rerio).

Mihaljevic I, Popovic M, Zaja R, Smital T.

BMC Genomics. 2016 Aug 12;17(1):626. doi: 10.1186/s12864-016-2981-y.


Organic anion transporter 2 transcript variant 1 shows broad ligand selectivity when expressed in multiple cell lines.

Hotchkiss AG, Berrigan L, Pelis RM.

Front Pharmacol. 2015 Oct 6;6:216. doi: 10.3389/fphar.2015.00216.


Role of solute carriers in response to anticancer drugs.

Li Q, Shu Y.

Mol Cell Ther. 2014 May 27;2:15. doi: 10.1186/2052-8426-2-15. Review.


The organic anion transporter (OAT) family: a systems biology perspective.

Nigam SK, Bush KT, Martovetsky G, Ahn SY, Liu HC, Richard E, Bhatnagar V, Wu W.

Physiol Rev. 2015 Jan;95(1):83-123. doi: 10.1152/physrev.00025.2013. Review.


Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins.

Lee WK, Jung SM, Kwak JO, Cha SH.

Electrolyte Blood Press. 2006 Mar;4(1):8-17. doi: 10.5049/EBP.2006.4.1.8. Review.


Uptake carriers and oncology drug safety.

Sprowl JA, Sparreboom A.

Drug Metab Dispos. 2014 Apr;42(4):611-22. doi: 10.1124/dmd.113.055806. Review.


Plasma membrane transporters in modern liver pharmacology.

Marin JJ.

Scientifica (Cairo). 2012;2012:428139. doi: 10.6064/2012/428139. Review.


Organic anion transporter 5 renal expression and urinary excretion in rats with vascular calcification.

Hazelhoff MH, Bulacio RP, Torres AM.

Biomed Res Int. 2013;2013:283429. doi: 10.1155/2013/283429.


Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites.

Swift B, Nebot N, Lee JK, Han T, Proctor WR, Thakker DR, Lang D, Radtke M, Gnoth MJ, Brouwer KL.

Drug Metab Dispos. 2013 Jun;41(6):1179-86. doi: 10.1124/dmd.112.048181.


Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.

Hagos Y, Wolff NA.

Toxins (Basel). 2010 Aug;2(8):2055-82. doi: 10.3390/toxins2082055. Review.


OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Roth M, Obaidat A, Hagenbuch B.

Br J Pharmacol. 2012 Mar;165(5):1260-87. doi: 10.1111/j.1476-5381.2011.01724.x. Review.


Mechanisms of membrane transport of folates into cells and across epithelia.

Zhao R, Diop-Bove N, Visentin M, Goldman ID.

Annu Rev Nutr. 2011 Aug 21;31:177-201. doi: 10.1146/annurev-nutr-072610-145133. Review.


PharmGKB summary: methotrexate pathway.

Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB.

Pharmacogenet Genomics. 2011 Oct;21(10):679-86. doi: 10.1097/FPC.0b013e328343dd93. No abstract available.


Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer.

Franke RM, Carducci MA, Rudek MA, Baker SD, Sparreboom A.

J Clin Oncol. 2010 Oct 20;28(30):4562-7. doi: 10.1200/JCO.2010.30.7025.


Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS).

Rödiger M, Zhang X, Ugele B, Gersdorff N, Wright SH, Burckhardt G, Bahn A.

Can J Physiol Pharmacol. 2010 Feb;88(2):141-6. doi: 10.1139/Y09-123.


Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Klaassen CD, Aleksunes LM.

Pharmacol Rev. 2010 Mar;62(1):1-96. doi: 10.1124/pr.109.002014. Review.


Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members.

Wu W, Baker ME, Eraly SA, Bush KT, Nigam SK.

Physiol Genomics. 2009 Jul 9;38(2):116-24. doi: 10.1152/physiolgenomics.90309.2008.


Physiology, structure, and regulation of the cloned organic anion transporters.

Srimaroeng C, Perry JL, Pritchard JB.

Xenobiotica. 2008 Jul;38(7-8):889-935. doi: 10.1080/00498250801927435 . Review.

Items per page

Supplemental Content

Support Center